Koo, Kaitlin <br/><br/>
Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Jun 2013 
 - 1785-91 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-013-1790-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--economics<br/>Bone Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Denosumab<br/>Diphosphonates--economics<br/>Humans<br/>Imidazoles--economics<br/>Zoledronic Acid